Cell and Gene Therapy World Congress 2024 Europe
"Driving Innovation, Addressing Significant Unmet Medical Needs, and Ultimately Improving Patient Outcomes"
3rd - 4th October 2024, Hilton London Kensington, LONDON, UK
KEY INDUSTRY EXPERT SPEAKERS
- Eric Halioua, President & Chief Executive Officer, PDC*line Pharma
- Adam Glen, Co-founder, Unicorn Bio
- Alex Blyth, Founder & CEO, Lift Biosciences
- Alexander Natz, Secretary General, EUCOPE
- Dr Lilian Hook, Director Cell, Apheresis & Gene Therapies, NHS Blood and Transplant
- Dr Theres Oakes, Head of Product Characterisation, Achilles Therapeutics
- Alberto Malerba, Lecturer in Gene Therapy, Royal Holloway University of London
- Dr. Ron Jortner, Founder/CEO, Aspire Biosciences
- Dr Nagy Habib, Professor of Surgery, Imperial College London
- Mohamed Oubihi, Founder and CEO, YAKUMED LIMITED
- Prof Harris Makatsoris, Professor of Manufacturing Systems, Department of Engineering, King’s College
- Eugean Jiwanmall, Senior Research Analyst, Independence Blue Cross
- Ana Koptina, Head of Regulatory Affairs, Mendus
- Prof Darius Widera, Prof of Stem Cell Biology & Regenerative Medicine, ERASMUS
- Dilip Patel, VP, Head of Global Market Access, Autolus
- Prof David James, Professor of Bioprocess Engineering, University of Sheffield
- Zhimei Du MD, VP of Process Sciences, Atara Biotherapeutics
- Anthony Newcomb, Chief Operating Officer, VectorY
- Cecilia Gotherstrom, Research Group leader, Associate Professor in Stem Cell Science, Karolinska Institute
- Stephen Judd, Process SME – Biologics / Cell & Gene Therapy, DPS Group
- Dr. Anand Srivastava, Chairman and Co-founder, Global Institute of Stem Cell Therapy and Research
- Amir Hefni, Global Head, Cell & Gene Therapy, Novartis
- Alejandro Fernandez-Martell, former Principal Bioprocess Engineer, Achilles Therapeutics
- Stuart M Curbishley, Chief Manufacturing and Chief Development Officer, adthera bio
- Elsa Abranches, Sr Director,Head of Cell Therapy Bioprocess Development and Manufacturing, Astrazeneca*
- Ben Doak, Head of Innovative Treatments, NHS England.
- Mark Fowler, Global Head of Procurement, Autolus
- Francois Hallac, Research Associate, King's College London
- Julia Djonova, Head, Advanced Therapy Medicinal Products, Swissmedic
- Thomas Muller, Head Of Directorate General, Federal Ministry of Health Germany
- Manal Morsy, EVP, Head of Global Regulatory Affairs, Athersys, Inc
- Yue (Dina) Du, Senior Scientist, Gene Therapy R&D, AstraZeneca
- Reagan Jarvis, Chief Executive Officer and Co-founder, Anocca
- Matthias Bozza, Director, Vector BioPharma
- Chris Williams, SVP Corporate Development, Autolus Ltd.
- Dr Lilian Hook, Director Cell, Apheresis & Gene Therapies, NHS Blood and Transplant
- Dr. Thomas Schochat, Clinical Assessor, Division Advanced Therapy Products, Swissmedic
- Daniel Gibson, Director of Cell and Gene, Anthony Nolan
- Vera Citro, P4FIT Early Stage Researcher, Keele University
Eric Halioua
President & Chief Executive Officer
JEFF LITER
CEO
ALEX BLYTH
Founder & CEO
ALEXANDER NATZ
Secretary General
DR LILIAN HOOK
Director Cell, Apheresis & Gene Therapies
DR. RON JORTNER
Founder/CEO
PROF HARRIS MAKATSORIS
Professor of Manufacturing Systems, Department of Engineering
King’s College London
PROF HARRIS MAKATSORIS
Professor of Manufacturing Systems, Department of Engineering
EUGEAN JIWANMALL
Senior Research Analyst
MARCO TRAUB
CEO
ADAM GLEN
Co-founder
ALBERTO MALERBA
Lecturer in Gene Therapy
Amir Hefni
Global Head for Cell & Gene Therapy
DR NAGY HABIB
Professor of Surgery
Dilip Patel
VP, Head of Global Market Access
MANAL MORSY
Executive Vice President, Head of Global Regulatory Affairs
THOMAS MUELLER
Head of Directorate General “Drugs, Medical Devices, Biotechnology”
Federal Ministry of Health, Germany
THOMAS MUELLER
Head of Directorate General “Drugs, Medical Devices, Biotechnology”
REAGAN JARVIS
CEO and Co-founder
BEN DOAK
Head of Innovative Treatments
CECILIA GÖTHERSTRÖM
Research Group leader, Associate Professor in Stem Cell Science
Karolinska Institutet
CECILIA GÖTHERSTRÖM
Research Group leader, Associate Professor in Stem Cell Science
Daniel Gibson
Director of Cell and Gene
STUART M CURBISHLEY
Chief Manufacturing and Chief Development Officer
JULIA DJONOVA
Head, Advanced Therapy Medicinal Products
Dr Chris Williams
SVP Corporate Development
Dr. Thomas Schochat
Clinical Assessor, Division Advanced Therapy Products
MATTHIAS BOZZA
Director